Product Code: GVR-4-68041-015-1
Single-cell Proteomics Market Summary
The global single-cell proteomics market size was valued at USD 707.1 million in 2025 and is projected to grow from USD 807.7 million in 2026 to USD 2,017.8 million by 2033, at a CAGR of 14.0% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 46.4% in 2025. Market growth is driven by increasing adoption of single-cell analysis in precision medicine, drug discovery, and disease research, along with advancements in mass spectrometry, multiplexed proteomic technologies, and high-throughput single-cell analysis platforms.
Global Single-cell Proteomics Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global single-cell proteomics market report on the basis of product & services, technology, workflow, application, end use, and region.
- Product & Services Outlook (Revenue, USD Million, 2021 - 2033)
- Instruments
- Consumables & Reagents
- Software
- Services
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Mass Spectrometry-based Proteomics
- Mass Cytometry-based Proteomics
- Antibody-based Proteomics
- Imaging-based Proteomics
- Sequencing-based Proteomics
- Other Technologies
- Workflow Outlook (Revenue, USD Million, 2021 - 2033)
- Cell Isolation & Preparation
- Protein Labeling & Barcoding
- Protein Detection & Quantification
- Data Acquisition
- Data Analysis & Interpretation
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Clinical Diagnostics
- Drug Discovery
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospitals & Clinical Research Centers
- Contract Research Organizations
- Other End Users
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Product & Services Segment
- 1.1.1.2. Technology Segment
- 1.1.1.3. Workflow Segment
- 1.1.1.4. Application Segment
- 1.1.1.5. End Use Segment
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing Adoption of Precision Medicine
- 3.2.1.2. Rising Demand for High-Resolution Cellular Analysis
- 3.2.1.3. Increasing Investments in Single-Cell Research
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Complexity of Single-cell Proteomics Data Analysis
- 3.2.2.2. High Cost of Advanced Proteomics Instruments
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
Chapter 4. Product & Services Business Analysis
- 4.1. Segment Dashboard
- 4.2. Single-cell Proteomics Market: Product & Services Movement Analysis
- 4.3. Instruments
- 4.3.1. Instruments Market, 2021-2033 (USD Million)
- 4.4. Consumables & Reagents
- 4.4.1. Consumables & Reagents Market, 2021-2033 (USD Million)
- 4.5. Software
- 4.5.1. Software Market, 2021-2033 (USD Million)
- 4.6. Services
- 4.6.1. Services Market, 2021-2033 (USD Million)
Chapter 5. Technology Business Analysis
- 5.1. Segment Dashboard
- 5.2. Single-cell Proteomics Market: Technology Movement Analysis
- 5.3. Mass Spectrometry-based Proteomics
- 5.3.1. Mass Spectrometry-based Proteomics Market, 2021-2033 (USD Million)
- 5.4. Mass Cytometry-based Proteomics
- 5.4.1. Mass Cytometry-based Proteomics Market, 2021-2033 (USD Million)
- 5.5. Antibody-based Proteomics
- 5.5.1. Antibody-based Proteomics Market, 2021-2033 (USD Million)
- 5.6. Imaging-based Proteomics
- 5.6.1. Imaging-based Proteomics Market, 2021-2033 (USD Million)
- 5.7. Sequencing-based Proteomics
- 5.7.1. Sequencing-based Proteomics Market, 2021-2033 (USD Million)
- 5.8. Other Technologies
- 5.8.1. Other Technologies Market, 2021-2033 (USD Million)
Chapter 6. Workflow Business Analysis
- 6.1. Segment Dashboard
- 6.2. Single-cell Proteomics Market: Workflow Movement Analysis
- 6.3. Cell Isolation & Preparation
- 6.3.1. Cell Isolation & Preparation Market, 2021-2033 (USD Million)
- 6.4. Protein Labeling & Barcoding
- 6.4.1. Protein Labeling & Barcoding Market, 2021-2033 (USD Million)
- 6.5. Protein Detection & Quantification
- 6.5.1. Protein Detection & Quantification Market, 2021-2033 (USD Million)
- 6.6. Data Acquisition
- 6.6.1. Data Acquisition Market, 2021-2033 (USD Million)
- 6.7. Data Analysis & Interpretation
- 6.7.1. Data Analysis & Interpretation Market, 2021-2033 (USD Million)
Chapter 7. Application Business Analysis
- 7.1. Segment Dashboard
- 7.2. Single-cell Proteomics Market: Application Movement Analysis
- 7.3. Clinical Diagnostics
- 7.3.1. Clinical Diagnostics Market, 2021-2033 (USD Million)
- 7.4. Drug Discovery
- 7.4.1. Drug Discovery Market, 2021-2033 (USD Million)
- 7.5. Others
- 7.5.1. Others Market, 2021-2033 (USD Million)
Chapter 8. End Use Business Analysis
- 8.1. Segment Dashboard
- 8.2. Single-cell Proteomics Market: End Use Movement Analysis
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Pharmaceutical & Biotechnology Companies Market, 2021-2033 (USD Million)
- 8.4. Academic & Research Institutes
- 8.4.1. Academic & Research Institutes Market, 2021-2033 (USD Million)
- 8.5. Hospitals & Clinical Research Centers
- 8.5.1. Hospitals & Clinical Research Centers Market, 2021-2033 (USD Million)
- 8.6. Contract Research Organizations
- 8.6.1. Contract Research Organizations Market, 2021-2033 (USD Million)
- 8.7. Other End Users
- 8.7.1. Other End Users Market, 2021-2033 (USD Million)
Chapter 9. Regional Business Analysis
- 9.1. Single-cell Proteomics Market Share By Region, 2025 & 2033
- 9.2. North America
- 9.2.1. North America Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.2.2. U.S.
- 9.2.2.1. Key Country Dynamics
- 9.2.2.2. Competitive Scenario
- 9.2.2.3. Regulatory Framework
- 9.2.2.4. U.S. Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.2.3. Canada
- 9.2.3.1. Key Country Dynamics
- 9.2.3.2. Competitive Scenario
- 9.2.3.3. Regulatory Framework
- 9.2.3.4. Canada Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.2.4. Mexico
- 9.2.4.1. Key Country Dynamics
- 9.2.4.2. Competitive Scenario
- 9.2.4.3. Regulatory Framework
- 9.2.4.4. Mexico Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3. Europe
- 9.3.1. Europe Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.2. UK
- 9.3.2.1. Key Country Dynamics
- 9.3.2.2. Competitive Scenario
- 9.3.2.3. Regulatory Framework
- 9.3.2.4. UK Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.3. Germany
- 9.3.3.1. Key Country Dynamics
- 9.3.3.2. Competitive Scenario
- 9.3.3.3. Regulatory Framework
- 9.3.3.4. Germany Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.4. France
- 9.3.4.1. Key Country Dynamics
- 9.3.4.2. Competitive Scenario
- 9.3.4.3. Regulatory Framework
- 9.3.4.4. France Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.5. Italy
- 9.3.5.1. Key Country Dynamics
- 9.3.5.2. Competitive Scenario
- 9.3.5.3. Regulatory Framework
- 9.3.5.4. Italy Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.6. Spain
- 9.3.6.1. Key Country Dynamics
- 9.3.6.2. Competitive Scenario
- 9.3.6.3. Regulatory Framework
- 9.3.6.4. Spain Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.7. Denmark
- 9.3.7.1. Key Country Dynamics
- 9.3.7.2. Competitive Scenario
- 9.3.7.3. Regulatory Framework
- 9.3.7.4. Denmark Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.8. Sweden
- 9.3.8.1. Key Country Dynamics
- 9.3.8.2. Competitive Scenario
- 9.3.8.3. Regulatory Framework
- 9.3.8.4. Sweden Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.9. Norway
- 9.3.9.1. Key Country Dynamics
- 9.3.9.2. Competitive Scenario
- 9.3.9.3. Regulatory Framework
- 9.3.9.4. Norway Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.2. Japan
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Competitive Scenario
- 9.4.2.3. Regulatory Framework
- 9.4.2.4. Japan Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.3. China
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Competitive Scenario
- 9.4.3.3. Regulatory Framework
- 9.4.3.4. China Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.4. India
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Competitive Scenario
- 9.4.4.3. Regulatory Framework
- 9.4.4.4. India Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.5. Australia
- 9.4.5.1. Key Country Dynamics
- 9.4.5.2. Competitive Scenario
- 9.4.5.3. Regulatory Framework
- 9.4.5.4. Australia Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.6. Thailand
- 9.4.6.1. Key Country Dynamics
- 9.4.6.2. Competitive Scenario
- 9.4.6.3. Regulatory Framework
- 9.4.6.4. Thailand Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.7. South Korea
- 9.4.7.1. Key Country Dynamics
- 9.4.7.2. Competitive Scenario
- 9.4.7.3. Regulatory Framework
- 9.4.7.4. South Korea Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.5. Latin America
- 9.5.1. Latin America Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.5.2. Brazil
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Competitive Scenario
- 9.5.2.3. Regulatory Framework
- 9.5.2.4. Brazil Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.5.3. Argentina
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Competitive Scenario
- 9.5.3.3. Regulatory Framework
- 9.5.3.4. Argentina Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.6. MEA
- 9.6.1. MEA Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.6.2. South Africa
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Competitive Scenario
- 9.6.2.3. Regulatory Framework
- 9.6.2.4. South Africa Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.6.3. Saudi Arabia
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Competitive Scenario
- 9.6.3.3. Regulatory Framework
- 9.6.3.4. Saudi Arabia Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.6.4. UAE
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Competitive Scenario
- 9.6.4.3. Regulatory Framework
- 9.6.4.4. UAE Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.6.5. Kuwait
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Competitive Scenario
- 9.6.5.3. Regulatory Framework
- 9.6.5.4. Kuwait Single-cell Proteomics Market, 2021-2033 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Company Categorization
- 10.2. Company Market Share/ Position Analysis, 2025
- 10.3. Strategy Mapping
- 10.4. Company Profiles/Listing
- 10.4.1. Thermo Fisher Scientific Inc.
- 10.4.1.1. Overview
- 10.4.1.2. Financial Performance
- 10.4.1.3. Product Benchmarking
- 10.4.1.4. Strategic Initiatives
- 10.4.2. Bruker
- 10.4.2.1. Overview
- 10.4.2.2. Financial Performance
- 10.4.2.3. Product Benchmarking
- 10.4.2.4. Strategic Initiatives
- 10.4.3. Danaher Corporation (SCIEX)
- 10.4.3.1. Overview
- 10.4.3.2. Financial Performance
- 10.4.3.3. Product Benchmarking
- 10.4.3.4. Strategic Initiatives
- 10.4.4. Standard BioTools
- 10.4.4.1. Overview
- 10.4.4.2. Financial Performance
- 10.4.4.3. Product Benchmarking
- 10.4.4.4. Strategic Initiatives
- 10.4.5. BD
- 10.4.5.1. Overview
- 10.4.5.2. Financial Performance
- 10.4.5.3. Product Benchmarking
- 10.4.5.4. Strategic Initiatives
- 10.4.6. Agilent Technologies, Inc.
- 10.4.6.1. Overview
- 10.4.6.2. Financial Performance
- 10.4.6.3. Product Benchmarking
- 10.4.6.4. Strategic Initiatives
- 10.4.7. Waters Corporation
- 10.4.7.1. Overview
- 10.4.7.2. Financial Performance
- 10.4.7.3. Product Benchmarking
- 10.4.7.4. Strategic Initiatives
- 10.4.8. 10x Genomics
- 10.4.8.1. Overview
- 10.4.8.2. Financial Performance
- 10.4.8.3. Product Benchmarking
- 10.4.8.4. Strategic Initiatives
- 10.4.9. Seer, Inc.
- 10.4.9.1. Overview
- 10.4.9.2. Financial Performance
- 10.4.9.3. Product Benchmarking
- 10.4.9.4. Strategic Initiatives
- 10.4.10. Evosep Biosystems
- 10.4.10.1. Overview
- 10.4.10.2. Financial Performance
- 10.4.10.3. Product Benchmarking
- 10.4.10.4. Strategic Initiatives
- 10.4.11. Cellenion
- 10.4.11.1. Overview
- 10.4.11.2. Financial Performance
- 10.4.11.3. Product Benchmarking
- 10.4.11.4. Strategic Initiatives
- 10.4.12. Cytek Biosciences
- 10.4.12.1. Overview
- 10.4.12.2. Financial Performance
- 10.4.12.3. Product Benchmarking
- 10.4.12.4. Strategic Initiatives
- 10.4.13. Quantum-Si Incorporated
- 10.4.13.1. Overview
- 10.4.13.2. Financial Performance
- 10.4.13.3. Product Benchmarking
- 10.4.13.4. Strategic Initiatives